Population-based seroprevalence of prior infection with COVID-19 in Canada: implications for testing, economic revitalization and population health.

加拿大基于人群的既往感染过 COVID-19 的血清阳性率：对检测、经济振兴和人口健康的影响。

• 批准号: 429231
• 负责人: Drews Steven J
• 金额: $ 69.62万
• 依托单位: Canadian Blood Services (Ottawa)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-05-01 至 2021-05-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=429231&lang=en
• 关键词: Antibody Neutralization Assays; Blood Donors; Epidemiology; Methods Comparisons; Modelling; Pandemic Response; Public Health; Sars-Cov-2; Serologic Antibody Testing; Seroprevalence

Canadian Blood Services blood donors are healthy people from cities and smaller urban areas in all provinces in Canada except Quebec. Left over blood samples from blood donations will be randomly selected and tested for antibodies to COVID-19. Antibodies

加拿大血液服务中心的献血者是来自加拿大除魁北克外所有省份的城市和小城市地区的健康人。献血后剩余的血液样本将被随机抽取，并进行COVID-19抗体检测。抗体